Jesper Hastrup Svendsen
University of Copenhagen
406 Papers
1.6K Citations
Jesper Hastrup Svendsen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Medicine & Atrial fibrillation. The author has an hindex of 54, co-authored 365 publications. Previous affiliations of Jesper Hastrup Svendsen include Copenhagen University Hospital & Gentofte Hospital.
Chat about Author
Papers
Atrial fibrillation and cardiac fibrosis: A review on the potential of extracellular matrix proteins as biomarkers.
Alexander L. Reese-Petersen,Morten S. Olesen,Morten A. Karsdal,Jesper Hastrup Svendsen,Federica Genovese +4 more
TL;DR: An overview of the implication of fibrosis in AF, the different collagens and their significance, and the potential of using biomarkers of ECM remodeling as tools for understanding AF pathogenesis and identifying patients at risk for further disease progression are reviewed.
Cardiac magnetic resonance systematically overestimates mitral regurgitations by the indirect method.
Litten Bertelsen,Niels Vejlstrup,Laura Andreasen,Morten S. Olesen,Jesper Hastrup Svendsen +4 more
- 01 Jul 2020
TL;DR: Stroke volumes determined by flow decrease throughout the proximal aorta and are systematically lower than volumetrically measured stroke volumes, especially with increasing distance from the aortic valves.
High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation.
Morten S. Olesen,Lei Yuan,Bo Liang,Anders G. Holst,Nikolaj Nielsen,Jonas B. Nielsen,Paula L. Hedley,Michael Christiansen,Søren-Peter Olesen,Stig Haunsø,Nicole Schmitt,Thomas Jespersen,Jesper Hastrup Svendsen +12 more
TL;DR: In a cohort of patients with early-onset lone AF, a high prevalence of SCN5A mutations previously associated with LQTS3 were identified and functional investigations of the mutations revealed both compromised transient peak current and increased sustained current.
Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study
Lucas Yixi Xing,Søren Zöga Diederichsen,Søren Højberg,Derk W. Krieger,Claus Graff,Ruth Frikke-Schmidt,Morten S. Olesen,Axel Brandes,Lars Køber,Ketil Haugan,Jesper Hastrup Svendsen +10 more
TL;DR: In this article , the authors investigated the utility of N-terminal pro-B-type natriuretic peptide (proBNP) as a potential marker for screening efficacy with respect to AF yield and stroke prevention.
The Prevalence of Mutations in KCNQ1, KCNH2, and SCN5A in an Unselected National Cohort of Young Sudden Unexplained Death Cases
Bo Gregers Winkel,Maiken Kudahl Larsen,Knut Erik Berge,Trond P. Leren,Peter H. Nissen,Morten S. Olesen,Mads V. Hollegaard,Thomas Jespersen,Lei Yuan,Nikolaj Nielsen,Stig Haunsø,Jesper Hastrup Svendsen,Yinman Wang,Ingrid Bayer Kristensen,Henrik Jensen,Jacob Tfelt-Hansen,Jytte Banner +16 more
TL;DR: The prevalence of mutations in an unselected population of sudden unexplained deaths in a nationwide setting is investigated to investigate the prevalence of diseases causing mutations in the 3 major long‐QT syndrome genes in the general population.